Track Heartflow, Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Heartflow, Inc. Common Stock HTFL · Stock Open Heartflow, Inc. Common Stock in new tab

48.46 USD
P/E
72.33
EPS
0.67
P/B
15.06
ROE
-29.43
Target Price
63.13 USD
Heartflow, Inc. Common Stock logo

Heartflow, Inc. Common Stock

🧾 Earnings Recap – Q3 2026

HeartFlow’s shares fell 19.1% after earnings, despite raised full-year revenue and gross-margin guidance. The transcript does not identify a specific disappointment; management’s outlook was raised, so the selloff cannot be attributed to a guidance cut or a stated slowdown based on the available information.

  • Q3 revenue was $72.9 million, up 57% year over year; U.S. revenue increased 60%.
  • Management raised full-year revenue guidance to $262 million–$264 million, or 49%–50% year-over-year growth, and Plaque revenue guidance to $36 million–$37 million.
  • Non-GAAP gross-margin guidance increased to approximately 82.5%; the company reiterated its midterm target of 85%.
  • HeartFlow expects approximately 1,300 Plaque-activated accounts by year-end, with Plaque coverage reaching about 82% of U.S. lives.
  • The company expects 2026 new account activations to exceed the 340 added in 2025.
📅
Loading chart...
Key Metrics
Earnings dateMarch 17, 2027
P/E72.33
EPS0.67
Book Value3.22
Price to Book15.06
Debt/Equity9.18
% Insiders5.697%
Growth
Revenue Growth0.57%
Estimates
Forward P/E-182.76
Forward EPS-0.27
Target Mean Price63.13

DCF valuation

Model fair value for Heartflow, Inc. Common Stock (HTFL)
Result
Sign in to run the valuation for HTFL.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
8 analysts · consensus Strong buy · mean target 63.13 USD (low 44.00, high 70.00) · as of 15 Nov 2026
Low 44.00
Mean 63.13
High 70.00
Price 48.46
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Heartflow, Inc. Common Stock Logo Heartflow, Inc. Common Stock Analysis (HTFL)

USA Official Website Stock

Is Heartflow, Inc. Common Stock a good investment? Heartflow, Inc. Common Stock (HTFL) is currently trading at 48.46 USD. Market analysts have a consensus price target of 63.13 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 72.33. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Heartflow, Inc. Common Stock is expected to release its next earnings report on March 17, 2027. The market consensus estimate for Forward EPS is -0.27.

Investor FAQ

Does Heartflow, Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Heartflow, Inc. Common Stock?

Heartflow, Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be March 17, 2027. The company currently has a trailing EPS of 0.67.

Company Profile

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heartflow FFRCT Analysis, which calculates blood flow and pinpoints clinically; and Heartflow Plaque Analysis that provides a comprehensive assessment of coronary plaque, enabling optimized medical treatment strategies. Its platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. HeartFlow, Inc. was formerly known as Cardiovascular Simulation, Inc. and changed its name to HeartFlow, Inc. in May 2009. The company was incorporated in 2007 and is headquartered in San Francisco, California.

Exchange Ticker
US HTFL
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion